Landscape Capital Management L.L.C. bought a new position in shares of Centene Co. (NYSE:CNC – Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 16,216 shares of the company’s stock, valued at approximately $982,000.
Several other hedge funds have also modified their holdings of the stock. Pitcairn Co. lifted its holdings in Centene by 3.2% during the 4th quarter. Pitcairn Co. now owns 9,385 shares of the company’s stock worth $569,000 after buying an additional 293 shares in the last quarter. ExodusPoint Capital Management LP boosted its holdings in Centene by 51.1% in the fourth quarter. ExodusPoint Capital Management LP now owns 230,130 shares of the company’s stock valued at $13,941,000 after acquiring an additional 77,865 shares during the last quarter. Westpac Banking Corp increased its position in Centene by 53.5% in the fourth quarter. Westpac Banking Corp now owns 41,784 shares of the company’s stock worth $2,531,000 after purchasing an additional 14,560 shares during the period. Cinctive Capital Management LP raised its holdings in Centene by 46.7% during the 4th quarter. Cinctive Capital Management LP now owns 51,964 shares of the company’s stock worth $3,148,000 after purchasing an additional 16,544 shares during the last quarter. Finally, Bryce Point Capital LLC bought a new position in shares of Centene in the 4th quarter valued at about $1,140,000. 93.63% of the stock is owned by institutional investors.
Centene Stock Down 3.4 %
NYSE:CNC opened at $62.13 on Friday. The stock has a 50-day simple moving average of $59.72 and a 200 day simple moving average of $62.26. Centene Co. has a 52-week low of $55.03 and a 52-week high of $80.59. The company has a market cap of $30.82 billion, a PE ratio of 9.96, a PEG ratio of 0.80 and a beta of 0.40. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11.
Analyst Ratings Changes
Several equities analysts recently weighed in on CNC shares. Jefferies Financial Group lowered shares of Centene from a “hold” rating to an “underperform” rating and cut their price objective for the company from $68.00 to $52.00 in a report on Tuesday, December 10th. Oppenheimer reduced their price target on Centene from $95.00 to $85.00 and set an “outperform” rating on the stock in a research report on Friday, December 13th. StockNews.com lowered Centene from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. UBS Group upgraded Centene from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $79.00 to $80.00 in a research report on Friday, December 13th. Finally, JPMorgan Chase & Co. reissued an “overweight” rating and set a $75.00 price objective (down previously from $80.00) on shares of Centene in a research note on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat, Centene currently has a consensus rating of “Moderate Buy” and a consensus price target of $79.92.
Get Our Latest Stock Analysis on CNC
Centene Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
See Also
- Five stocks we like better than Centene
- 3 Warren Buffett Stocks to Buy Now
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Basic Materials Stocks Investing
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.